Factor H-related proteins as a protective evolutionary mechanism against microbial infections

IF 3.1 4区 医学 Q3 IMMUNOLOGY
Immunobiology Pub Date : 2026-05-01 Epub Date: 2026-05-05 DOI:10.1016/j.imbio.2026.153185
Rosario García-Sánchez , Alberto López-Lera , Laura González-Sánchez , Fernando Corvillo , Agustín Tortajada , Pilar Sánchez-Corral
{"title":"Factor H-related proteins as a protective evolutionary mechanism against microbial infections","authors":"Rosario García-Sánchez ,&nbsp;Alberto López-Lera ,&nbsp;Laura González-Sánchez ,&nbsp;Fernando Corvillo ,&nbsp;Agustín Tortajada ,&nbsp;Pilar Sánchez-Corral","doi":"10.1016/j.imbio.2026.153185","DOIUrl":null,"url":null,"abstract":"<div><div>Factor H (FH) is the main regulator of the complement alternative pathway, and it is essential to prevent complement-mediated autologous damage. Many pathogens express FH-binding proteins on their surface that recruit human FH as a strategy to avoid or limit their elimination by the host complement. The FH-Related Proteins (FHR-1, FHR-2, FHR-3, FHR-4A, and FHR-5) share sequential and structural homology with FH that result from their common ancestry, but none of them can regulate complement like FH. While the precise contribution of FHRs in human complement is still not completely understood, it has been proposed that these proteins have been conserved along evolution because they outcompete FH binding to the microbial surfaces, thus allowing pathogen elimination. In this review, we recapitulate the current evidence of the interaction between FHRs and pathogens. We describe the results from “in vitro” studies with microbial isolates and purified proteins, and the few studies that have addressed the quantification of FH and FHRs in patients during infection. We also provide an analysis comparing the frequency of common genetic variants, including <em>ΔCFHR3-CFHR1,</em> in different geographical regions, and the incidence of Invasive Meningococcal Disease. All the data are discussed in the context of the role of FHRs as FH-deregulators, and at the light of recent findings supporting a function as complement activators.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"231 3","pages":"Article 153185"},"PeriodicalIF":3.1000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunobiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0171298526000318","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Factor H (FH) is the main regulator of the complement alternative pathway, and it is essential to prevent complement-mediated autologous damage. Many pathogens express FH-binding proteins on their surface that recruit human FH as a strategy to avoid or limit their elimination by the host complement. The FH-Related Proteins (FHR-1, FHR-2, FHR-3, FHR-4A, and FHR-5) share sequential and structural homology with FH that result from their common ancestry, but none of them can regulate complement like FH. While the precise contribution of FHRs in human complement is still not completely understood, it has been proposed that these proteins have been conserved along evolution because they outcompete FH binding to the microbial surfaces, thus allowing pathogen elimination. In this review, we recapitulate the current evidence of the interaction between FHRs and pathogens. We describe the results from “in vitro” studies with microbial isolates and purified proteins, and the few studies that have addressed the quantification of FH and FHRs in patients during infection. We also provide an analysis comparing the frequency of common genetic variants, including ΔCFHR3-CFHR1, in different geographical regions, and the incidence of Invasive Meningococcal Disease. All the data are discussed in the context of the role of FHRs as FH-deregulators, and at the light of recent findings supporting a function as complement activators.
因子h相关蛋白作为微生物感染的保护性进化机制
因子H (FH)是补体替代途径的主要调节因子,对预防补体介导的自体损伤至关重要。许多病原体在其表面表达FH结合蛋白,招募人类FH作为避免或限制其被宿主补体消除的策略。FH相关蛋白(FHR-1, FHR-2, FHR-3, FHR-4A和FHR-5)与FH具有序列和结构同源性,这是由于它们的共同祖先,但它们都不能像FH那样调节补体。虽然fhr在人类补体中的确切作用仍未完全了解,但有人提出,这些蛋白质在进化过程中一直保持保守,因为它们与微生物表面的fhr结合竞争,从而允许病原体消除。在这篇综述中,我们概述了目前关于fhr与病原体相互作用的证据。我们描述了用微生物分离物和纯化蛋白进行的“体外”研究的结果,以及少数涉及感染期间患者FH和fhr定量的研究。我们还提供了一项分析,比较了不同地理区域常见遗传变异(包括ΔCFHR3-CFHR1)的频率和侵袭性脑膜炎球菌病的发病率。所有数据都是在fhr作为fh解除管制者的作用背景下讨论的,并根据最近的研究结果支持补体激活剂的功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Immunobiology
Immunobiology 医学-免疫学
CiteScore
5.00
自引率
3.60%
发文量
108
审稿时长
55 days
期刊介绍: Immunobiology is a peer-reviewed journal that publishes highly innovative research approaches for a wide range of immunological subjects, including • Innate Immunity, • Adaptive Immunity, • Complement Biology, • Macrophage and Dendritic Cell Biology, • Parasite Immunology, • Tumour Immunology, • Clinical Immunology, • Immunogenetics, • Immunotherapy and • Immunopathology of infectious, allergic and autoimmune disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书